Blood groups A, B, AB run higher diabetes risk than group O

Image
ANI Washington
Last Updated : Dec 20 2014 | 9:43 PM IST

A new study has demonstrated that people with blood groups A, B and AB are at a higher risk of type 2 diabetes than people with blood group O.

The study of more than 80,000 women has uncovered different risks of developing type 2 diabetes associated with different blood groups, with the biggest difference a 35 percent increased risk of type 2 diabetes found in those with group B, Rhesus factor positive (R+) blood compared with the universal donor group O, Rhesus factor negative (R-).

Dr Guy Fagherazzi and his colleagues took data from 82,104 women from the large prospective E3N cohort in France followed between 1990 and 2008. The objective of this study was to evaluate the relationship of ABO blood type (A, B, AB and O), Rhesus factor (positive or negative) and a combination of the two (ABOxRhesus) with type 2 diabetes (T2D).

The results showed that, compared with women with group O blood, women with group A were 10 percent more likely to develop T2D, and those with group B 21 percent more likely (both statistically significant). The AB group was 17 percent more likely to develop T2D, but this result was not statistically significant. When looking solely at R+ versus R- women, neither group was at increased risk of developing T2D compared with the other.

Fagherazzi said that the present study shows for the first time in a large prospective cohort that specific ABO blood groups are associated with an increased type 2 diabetes risk.

Fagherazzi concludes that their findings support a strong relationship between blood group and diabetes risk, with participants with the O blood type having a lower risk of developing type 2 diabetes. Therefore, the effects of blood groups should be investigated in future clinical and epidemiological studies on diabetes. Further pathophysiological research is also needed to determine why the individuals with blood type O have a lower risk of type 2 diabetes.

The study is published in Diabetologia, the journal of The European Association for the Study of Diabetes.

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Dec 20 2014 | 3:18 PM IST

Next Story